"Designing Growth Strategies is in our DNA"

Fetal Bovine SerumMarket Size, Share and Global Trend By Application (Drugs discovery, In-vitro fertilization, Vaccine production, Cell-based research, Diagnostics and biopharmaceutical manufacturing, Others), By End Users (Pharmaceutical & biotechnology companies, Contract Research Organizations (CRO), Academic and research organizations, Others) and Geography Forecast till 2030

Region : Global | Report ID: FBI101123 | Status : Ongoing



Fetal Bovine Serum (FBS) is derived from the blood of a bovine fetus with the help of closed collection system, generally at a slaughterhouse. The serum is generally used as a supplement to the basal growth medium in cell culture. The most common type of serum is fetal bovine serum (FBS) because of its high content of embryonic growth-promoting factors. In cell culture, the serum provides a wide variety of advantages such as low molecular weight nutrients, macromolecular proteins, carrier proteins of water-insoluble components, and other necessary compounds for the in vitro growth of cells, such as hormones and attachment factors.

A study published by the National Center for Biotechnology Information (NCBI), stated that the fetal bovine serum has experienced increased prices by greater than 300% due to the increased demand and limited availability. In January 2017, Nucleus Biologics launched its first ever premium cell culture product for the enabling of scientific breakthroughs in research & development.

To gain extensive insights into the market, Request for Customization

One of the key market drivers responsible for the growth of the fetal bovine serum market is the increasing demand of fetal bovine serum for research & development initiatives across a number of fields, especially in the pharmaceutical and drug development domain. Combined with this, increasing the prevalence of acute and chronic diseases globally, and effectivity of fetal bovine serum is expected to boost the adoption of fetal bovine serum, which will eventually fuel the growth of the global fetal bovine serum market during the forecast period.

The factor that is expected to inhibit the growth of the global fetal bovine serum market is the growing ethical concerns associated with the collection of the fetal bovine serum. Some of the other factors that might inhibit the growth of the market are volatile pricing of the fetal bovine serum and the disparity across the various geographical segments from which the serum is sourced and collected.

Key Players Covered

Some of the major companies that are present in the global fetal bovine serum market are Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Moregate Biotech, Atlanta Biologicals, Inc., Gemini Bio-Products, and Bovogen Biologicals Pty Ltd and other players.




By Application

· Drugs discovery

· In-vitro fertilization

· Vaccine production

· Cell-based research

· Diagnostics and biopharmaceutical manufacturing

· Others

By End Users

· Pharmaceutical & biotechnology companies

· Contract Research Organizations (CRO)

· Academic and research organizations

· Others

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


At present, in terms of application, drugs discovery and cell-based research are expected to hold a significant share of the global fetal bovine serum market owing to the higher efficiency of fetal bovine serum in drug discovery and cell-based research.

Key Insights

  • Regulatory scenario for key countries

  • Recent industry developments such as partnerships, mergers, and acquisitions

  • Analysis of different fetal bovine serum types by treatment

Regional Analysis

The global fetal bovine serum market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two largest markets for fetal bovine serum at present and they are expected to account for a larger proportion of the market during the forecast period. This is due to the reason that these regions hold huge populations of bovine and cattle to enable the production of fetal bovine serum and also the high proportion of the R&D activity undertaken. In the Asia Pacific, Australia is expected to provide the largest market opportunity owing to the huge proportion of the cattle population and favorable government support for research and development.

Key Industry Developments

  • In July 2017, GE Healthcare and Oritain announced the launch of a testing service for the combatting of serum fraud.

  • In January 2017, Nucleus Biologics launched the first ever premium fetal bovine serum for the enabling of the scientific breakthroughs while the R&D initiatives are being undertaken.

  • In November 2014, InVitria launched the ZAP-SR (Serum Reducer), a product for the users of cell culture, who are currently using the fetal bovine serum (FBS) and are facing product shortages and escalating costs.

  • Ongoing
  • 2022
  • 2019-2021


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.